Treatment Options for Multidrug-Resistant Acinetobacter Species

Author： Gilad Jacob  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.2, 2008-01, pp. : 165-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of multidrug-resistant Acinetobacter species infection often requires the use of drugs with which there is limited clinical experience

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 11, 2008-11 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I.   Colebunders R.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite

Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?

By Giamarellou Helen   Poulakou Garyphallia  

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1879-1901

Adis International

Access to resources Recommend Favorite

Multidrug-Resistant Streptococcus pneumoniae Infections: Current and Future Therapeutic Options

By Françoise Van Bambeke  

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2355-2382

Adis International

Access to resources Recommend Favorite

A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis

By Fitzpatrick Christopher   Floyd Katherine  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 63-80

Adis International

Access to resources Recommend Favorite